[FG] Donath Marc

Lazaridis, I.I. et al. (2024) ‘Family planning, reproductive health and pregnancy after bariatric surgery: a survey of bariatric healthcare professionals in Switzerland’, Swiss Medical Weekly, 154(12), p. 3841. Available at: https://doi.org/10.57187/s.3841.

Wälchli-Popovic, Milica et al. (2024) ‘Effects of interleukin-1 receptor antagonism in women with polycystic ovary syndrome—the FertIL trial’, Frontiers in Endocrinology. 11.09.2024, 15. Available at: https://doi.org/10.3389/fendo.2024.1435698.

Lüthi, Hualin et al. (2024) ‘Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial’, eClinicalMedicine, 68, p. 102429. Available at: https://doi.org/10.1016/j.eclinm.2024.102429.

Urwyler, Sandrine A et al. (2024) ‘Efficacy of cabergoline in non-irradiated patients with acromegaly: a multi-centre cohort study’, European Journal of Endocrinology, 190(1), pp. 113–120. Available at: https://doi.org/10.1093/ejendo/lvae003.

Baldrich, Adrian et al. (2024) ‘Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency’, Journal of Clinical Immunology, 44. Available at: https://doi.org/10.1007/s10875-024-01667-z.

Bosch, A.J.T. et al. (2023) ‘Lung versus gut exposure to air pollution particles differentially affect metabolic health in mice’, Particle and Fibre Toxicology, 20(1). Available at: https://doi.org/10.1186/s12989-023-00518-w.

Steiger, Laura et al. (2023) ‘Protocol for isolation and spectral flow cytometry analysis of immune cells from the murine exocrine and endocrine pancreas’, STAR Protocols, 4(4), p. 102664. Available at: https://doi.org/10.1016/j.xpro.2023.102664.

de Baat, Axel et al. (2023) ‘Cystine/glutamate antiporter System xc- deficiency impairs insulin secretion in mice’, Diabetologia, 66(11), pp. 2062–2074. Available at: https://doi.org/10.1007/s00125-023-05993-6.

de Baat, Axel et al. (2023) ‘Cystine/Glutamate antiporter system xc- deficiency impairs macrophage glutathione metabolism and cytokine production’, PLOS ONE, 18(10), p. e0291950. Available at: https://doi.org/10.1371/journal.pone.0291950.

Perakakis, N. et al. (2023) ‘Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases’, The Lancet Diabetes and Endocrinology, 11(9), pp. 675–693. Available at: https://doi.org/10.1016/s2213-8587(23)00154-7.

Ferreira, Antonio et al. (2023) ‘Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass’, Diabetes Technology and Therapeutics, 25(7), pp. 467–475. Available at: https://doi.org/10.1089/dia.2023.0036.

Urwyler, Sandrine A. and Karavitaki, Niki (2023) ‘Refractory lactotroph adenomas’, Pituitary, 26(3), pp. 273–277. Available at: https://doi.org/10.1007/s11102-023-01305-8.

Ebrahimi F and Ludvigsson JF (2023) ‘Letter to the editor: Association between birth weight, preterm birth, and nonalcoholic fatty liver disease in a community-based cohort.’, 77(5). Available at: https://doi.org/10.1097/hep.0000000000000273.

Vielhaber JA et al. (2023) ‘Severe Abdominal Pain After Bariatric Surgery: Think Twice—Think Porphyria!’, 33(5). Available at: https://doi.org/10.1007/s11695-023-06555-w.

Komminoth, Mathis et al. (2023) ‘Glucocorticoid withdrawal and glucocorticoidinduced adrenal insufficiency: Study protocol of the randomized controlled «TOASST’ (Taper Or Abrupt Steroid STop) multicenter trial’, PLoS ONE, 18(4 April). Available at: https://doi.org/10.1371/journal.pone.0281585.

Lengsfeld, Sophia et al. (2023) ‘Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial’, eClinicalMedicine, 57, p. 101865. Available at: https://doi.org/10.1016/j.eclinm.2023.101865.

Jung, Ruedi et al. (2023) ‘Effect of a physical activity intervention on lower body bone health in childhood cancer survivors: A randomized controlled trial (SURfit)’, International Journal of Cancer, 152(2), pp. 162–171. Available at: https://doi.org/10.1002/ijc.34234.

Borisov, Angel N. et al. (2023) ‘Canagliflozin and Metabolic Associated Fatty Liver Disease in Patients With Diabetes Mellitus: New Insights From CANVAS’, Journal of Clinical Endocrinology and Metabolism, 108, pp. 2940–2949. Available at: https://doi.org/10.1210/clinem/dgad249.

Daetwyler, Eveline et al. (2023) ‘Nivolumab-induced diabetes mellitus—a case report with literature review of the treatment options’, Frontiers in Immunology, 14. Available at: https://doi.org/10.3389/fimmu.2023.1248919.

de Baat, A. et al. (2023) ‘Cystine/Glutamate antiporter system x<inf>c</inf>deficiency impairs macrophage glutathione metabolism and cytokine production’, PLoS ONE, 18. Available at: https://doi.org/10.1371/journal.pone.0291950.

de Baat, A. et al. (2023) ‘Cystine/glutamate antiporter System x<inf>c</inf>^- deficiency impairs insulin secretion in mice’, Diabetologia, 66, pp. 2062–2074. Available at: https://doi.org/10.1007/s00125-023-05993-6.

de Baat, Axel et al. (2023) ‘Physiological role of cytokines in the regulation of mammalian metabolism’, Trends in Immunology, 44(8), pp. 613–627. Available at: https://doi.org/10.1016/j.it.2023.06.002.

Ferrari, Serge and Meier, Christian (2023) ‘Reply to comment by Suhm N on: Ferrari S, et al. 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO)’, Swiss Medical Weekly, 153. Available at: https://doi.org/10.57187/smw.2023.40075.

Guha Ray, Preetam et al. (2023) ‘A versatile bioelectronic interface programmed for hormone sensing.’, Nature Communications, 14. Available at: https://doi.org/10.1038/s41467-023-39015-1.

Minder, Anna-Elisabeth et al. (2023) ‘Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria.’, Life, 13(4), p. 1066. Available at: https://doi.org/10.3390/life13041066.

Quansah, Dan Yedu et al. (2023) ‘C-reactive protein during pregnancy and in the early postpartum predicts adverse metabolic health outcomes at 1 year postpartum in women with gestational diabetes’, Cardiovascular Diabetology, 22. Available at: https://doi.org/10.1186/s12933-023-02034-9.

Steiger, Laura et al. (2023) ‘Protocol for isolation and spectral flow cytometry analysis of immune cells from the murine exocrine and endocrine pancreas’, STAR Protocols, 4(4), p. 102664. Available at: https://doi.org/10.1016/j.xpro.2023.102664.

Wirth, Fabian et al. (2023) ‘A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models’, Nature Communications, 14. Available at: https://doi.org/10.1038/s41467-023-41986-0.

Meier DT et al. (2022) ‘Prohormone convertase 1/3 deficiency causes obesity due to impaired proinsulin processing’, Nature Communications, 13(1), p. 4761. Available at: https://doi.org/10.1038/s41467-022-32509-4.

R Charlier SH et al. (2022) ‘Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case–control study’, Cardiovascular Diabetology, 21(1), p. 2. Available at: https://doi.org/10.1186/s12933-021-01432-1.

Donath MY (2022) ‘Type 1 diabetes: what is the role of autoimmunity in β cell death?’, Journal of Clinical Investigation, 132(20). Available at: https://doi.org/10.1172/JCI164460.

Atila C et al. (2022) ‘The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study’, Pituitary, 25(4), pp. 636–644. Available at: https://doi.org/10.1007/s11102-022-01240-0.

Wiedemann SJ et al. (2022) ‘The cephalic phase of insulin release is modulated by IL-1β’, Cell Metabolism, 34(7), pp. 991–1003.e6. Available at: https://doi.org/10.1016/j.cmet.2022.06.001.

Bischof E et al. (2022) ‘Adherence to bone health guidelines in patients with hormone receptor-positive early breast cancer: Status and clinical impact in a Swiss cohort experience’, Bone Reports, 16, p. 101160. Available at: https://doi.org/10.1016/j.bonr.2021.101160.

Koehler V.F. et al. (2022) ‘Medullary thyroid cancer with ectopic Cushing’s syndrome: A multicentre case series’, Clinical Endocrinology, 96(6), pp. 847–856. Available at: https://doi.org/10.1111/cen.14617.

Sewing L et al. (2022) ‘Bone Microarchitecture and Strength in Long-Standing Type 1 Diabetes’, Journal of Bone and Mineral Research, 37(5), pp. 837–847. Available at: https://doi.org/10.1002/jbmr.4517.

Hepprich, M. et al. (2022) Glucagon-like peptide-1 receptor PET/CT in patients with and without post gastric bypass hypoglycemia – a prospective, matched case-control study. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-1561857/v1.

Rohm TV et al. (2022) ‘Inflammation in obesity, diabetes, and related disorders’, Immunity, 55(1), pp. 31–55. Available at: https://doi.org/10.1016/j.immuni.2021.12.013.

Fawcett C et al. (2022) ‘Effects of Rapid On-Site Evaluation on Diagnostic Accuracy of Thyroid Fine-Needle Aspiration.’, Acta cytologica, 66(5), pp. 371–378. Available at: https://doi.org/10.1159/000522662.

Hepprich, Matthias et al. (2022) ‘Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial’, eClinicalMedicine, 53. Available at: https://doi.org/10.1016/j.eclinm.2022.101649.

Hoffmann, C. et al. (2022) ‘Liver, NAFLD and COVID-19’, Hormone and Metabolic Research [Preprint]. Available at: https://doi.org/10.1055/a-1834-9008.

Jehle‐kunz, Sigrid et al. (2022) ‘Risk Factors, Manifestation, and Awareness of Osteoporosis among Patients of Various Specialists in Switzerland: Results of a National Survey’, Healthcare (Switzerland), 10. Available at: https://doi.org/10.3390/healthcare10020295.

Meier, Daniel T et al. (2022) ‘Prohormone convertase 1/3 deficiency causes obesity due to impaired proinsulin processing.’, Nature communications, 13(1), p. 4761. Available at: https://doi.org/10.1038/s41467-022-32509-4.

Paccou J. et al. (2022) ‘Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS)’, Bone, 154. Available at: https://doi.org/10.1016/j.bone.2021.116236.

Potasso L et al. (2022) ‘Effect of hyponatremia normalization on osteoblast function in patients with SIAD’, European Journal of Endocrinology, 186(1), pp. 1–8. Available at: https://doi.org/10.1530/eje-21-0604.

Vavanikunnel, J. et al. (2022) ‘Determinants of low bone turnover in type 2 diabetes-the role of PTH’, Calcif Tissue Int, 111(6), pp. 587–596. Available at: https://doi.org/10.1007/s00223-022-01022-7.

Matthias Hepprich et al. (2022) ‘Glucagon-Like Peptide-1 Receptor Pet/Ct in Patients with and Without Post Gastric Bypass Hypoglycemia: A Prospective, Matched Case-Control Study’, J Gastrointest Dig Systems [Preprint]. 15-Jun-2022, (12). Available at: https://doi.org/10.4172/2161-069x.1000686.

Tynes M., Hepprich M. and Timper K. (2021) ‘Regular intake of energy drinks and multivitamin supplements is associated with elevated plasma vitamin B6 levels in post-bariatric patients’, Scientific Reports, 11(1). Available at: https://doi.org/10.1038/s41598-021-97205-7.

Raess N. et al. (2021) ‘Influence of Prednisone on Inflammatory Biomarkers in Community-Acquired Pneumonia: Secondary Analysis of a Randomized Trial’, Journal of Clinical Pharmacology, 61(11), pp. 1406–1414. Available at: https://doi.org/10.1002/jcph.1914.

Sailer C.O. et al. (2021) ‘Oxytocin levels in response to pituitary provocation tests in healthy volunteers’, European Journal of Endocrinology, 185(3), pp. 355–364. Available at: https://doi.org/10.1530/EJE-21-0346.

Urwyler SA et al. (2021) ‘Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers’, Pituitary, 24(4), pp. 555–563. Available at: https://doi.org/10.1007/s11102-021-01132-9.

Zweck E., Hepprich M and Donath M.Y. (2021) ‘Predictors of Postprandial Hypoglycemia After Gastric Bypass Surgery: a Retrospective Case-Control Study’, Obesity Surgery, 31(6), pp. 2497–2502. Available at: https://doi.org/10.1007/s11695-021-05277-1.

Rohm TV et al. (2021) ‘Obesity in Humans Is Characterized by Gut Inflammation as Shown by Pro-Inflammatory Intestinal Macrophage Accumulation’, Frontiers in Immunology, 12, p. 668654. Available at: https://doi.org/10.3389/fimmu.2021.668654.

Schiavon M. et al. (2021) ‘Model-Based Assessment of C-Peptide Secretion and Kinetics in Post Gastric Bypass Individuals Experiencing Postprandial Hyperinsulinemic Hypoglycemia’, Frontiers in Endocrinology, 12. Available at: https://doi.org/10.3389/fendo.2021.611253.

Hepprich M et al. (2021) ‘Switch-to-Semaglutide Study (STS-Study): a Retrospective Cohort Study’, Diabetes Therapy, 12(3), pp. 943–954. Available at: https://doi.org/10.1007/s13300-021-01016-y.

Netea MG et al. (2021) ‘Author Correction: A guiding map for inflammation.’, 22(2). Available at: https://doi.org/10.1038/s41590-020-00846-5.

Hepprich, M., Donath, M.Y. and Hemkens, L.G. (2021) ‘Patient involvement to inform the design of a clinical trial in postbariatric hypoglycaemia’. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-55915/v2.

Donath MY (2021) ‘Glucose or Insulin, Which Is the Culprit in Patients with COVID-19 and Diabetes?’, Cell Metabolism, 33(1), pp. 2–4. Available at: https://doi.org/10.1016/j.cmet.2020.11.015.

Böni-Schnetzler, Marianne et al. (2021) ‘IL-1beta promotes the age-associated decline of beta cell function’, iScience, 24. Available at: https://doi.org/10.1016/j.isci.2021.103250.

Charlier, Sarah et al. (2021) ‘Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study’, Journal of Clinical Endocrinology and Metabolism, 106(2), pp. 554–566. Available at: https://doi.org/10.1210/clinem/dgaa796.

Tsourdi E et al. (2021) ‘Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS’, Journal of Clinical Endocrinology and Metabolism, 106(1), pp. 264–281. Available at: https://doi.org/10.1210/clinem/dgaa756.

Winzeler B et al. (2021) ‘A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia’, Journal of Clinical Investigation, 131(20). Available at: https://doi.org/10.1172/jci151800.

Wueest S. et al. (2021) ‘Il-6 receptor blockade increases circulating adiponectin levels in people with obesity: An explanatory analysis’, Metabolites, 11(2), pp. 1–7. Available at: https://doi.org/10.3390/metabo11020079.

Hepprich M, Donath MY and Hemkens L.G. (2020) ‘Patient involvement to inform the design of a clinical trial in postbariatric hypoglycaemia’, BMC Medical Research Methodology, 20(1), p. 290. Available at: https://doi.org/10.1186/s12874-020-01171-z.

Wiedemann SJ et al. (2020) ‘Evidence for cephalic phase insulin release in humans: A systematic review and meta-analysis’, Appetite, 155, p. 104792. Available at: https://doi.org/10.1016/j.appet.2020.104792.

Dahlby T et al. (2020) ‘Enhancer of zeste homolog 2 (Ezh2) mediates glucolipotoxicity-induced apoptosis in β-cells’, International Journal of Molecular Sciences, 21(21), pp. 1–18. Available at: https://doi.org/10.3390/ijms21218016.

Rosenberg R et al. (2020) ‘[Adrenal tumors].’, Therapeutische Umschau. Revue therapeutique, 77(9), pp. 441–448. Available at: https://doi.org/10.1024/0040-5930/a001216.

Zürcher SJ et al. (2020) ‘High impact physical activity and bone health of lower extremities in childhood cancer survivors: A cross-sectional study of SURfit.’, International journal of cancer, 147(7), pp. 1845–1854. Available at: https://doi.org/10.1002/ijc.32963.

Ferrari S et al. (2020) ‘2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO)’, Swiss Medical Weekly, 150(3940), p. w20352. Available at: https://doi.org/10.4414/SMW.2020.20352.

Antwi K et al. (2020) ‘Pitfalls in the Detection of Insulinomas With Glucagon-Like Peptide-1 Receptor Imaging’, Clinical Nuclear Medicine, 45(9), pp. E386–E392. Available at: https://doi.org/10.1097/RLU.0000000000003124.

Schneider R et al. (2020) ‘GLP-1 Analogues as a Complementary Therapy in Patients after Metabolic Surgery: a Systematic Review and Qualitative Synthesis’, Obesity Surgery, 30(9), pp. 3561–3569. Available at: https://doi.org/10.1007/s11695-020-04750-7.

Pepe J. et al. (2020) ‘Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF’, Journal of Clinical Endocrinology and Metabolism, 105(8), pp. 2487–2506. Available at: https://doi.org/10.1210/clinem/dgaa306.

Burmester GR et al. (2020) ‘Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial’, The Lancet, 396(10246), pp. 267–276. Available at: https://doi.org/10.1016/S0140-6736(20)30636-X.

Sarcevic J et al. (2020) ‘Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism’. Frontiers Media S.A., 11. Available at: https://doi.org/10.3389/fimmu.2020.01435.

Gerendas BS et al. (2020) ‘Ganglion cell layer thickening in well-controlled patients with type 1 diabetes: an early sign for diabetic retinopathy?’, Acta Ophthalmologica, 98(3), pp. e292–e300. Available at: https://doi.org/10.1111/aos.14273.

Hepprich M et al. (2020) ‘Postprandial Hypoglycemia in Patients after Gastric Bypass Surgery Is Mediated by Glucose-Induced IL-1β’, Cell Metabolism, 31(4), pp. 699–709.e5. Available at: https://doi.org/10.1016/j.cmet.2020.02.013.

Brykczynska U et al. (2020) ‘Distinct Transcriptional Responses across Tissue-Resident Macrophages to Short-Term and Long-Term Metabolic Challenge’, Cell Reports, 30(5), pp. 1627–1643.e7. Available at: https://doi.org/10.1016/j.celrep.2020.01.005.

Ellingsgaard H et al. (2020) ‘GLP-1 secretion is regulated by IL-6 signalling: a randomised, placebo-controlled study’, Diabetologia, 63(2), pp. 362–373. Available at: https://doi.org/10.1007/s00125-019-05045-y.

Müller F et al. (2020) ‘Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee’, Knee Surgery, Sports Traumatology, Arthroscopy, 28(2), pp. 408–417. Available at: https://doi.org/10.1007/s00167-019-05598-w.

Hepprich M et al. (2020) ‘Brunner’s Gland Hyperplasia in a Patient after Roux-Y Gastric Bypass: An Important Pitfall in GLP-1 Receptor Imaging’. Hindawi Limited410 Park Avenue, 15th Floor, 287 pmbNew YorkNY 10022, 2020. Available at: https://doi.org/10.1155/2020/4510910.

Meienberg F (2020) ‘[The adrenal incidentaloma].’, Therapeutische Umschau. Revue therapeutique, 77(8), pp. 357–360. Available at: https://doi.org/10.1024/0040-5930/a001204.

Schulze, Friederike et al. (2020) ‘Inhibition of IL-1beta improves Glycaemia in a Mouse Model for Gestational Diabetes’, Scientific Reports, 10(1), p. 3035. Available at: https://doi.org/10.1038/s41598-020-59701-0.

Trinh B, Donath MY and Läubli H (2020) ‘Successful treatment of immune checkpoint inhibitor-induced diabetes with infliximab. Diabetes Care 2019;42:e153-e154’, 43(1). Available at: https://doi.org/10.2337/dci19-0058.

Donath MY, Dinarello CA and Mandrup-Poulsen T (2019) ‘Targeting innate immune mediators in type 1 and type 2 diabetes’, Nature Reviews Immunology, 19(12), pp. 734–746. Available at: https://doi.org/10.1038/s41577-019-0213-9.

Anastasilakis AD et al. (2019) ‘Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society’, Bone, 127, pp. 401–418. Available at: https://doi.org/10.1016/j.bone.2019.07.006.

Donath MY (2019) ‘Designer cytokine for the treatment of diabetes’, Nature Metabolism, 1(10), pp. 933–934. Available at: https://doi.org/10.1038/s42255-019-0130-z.

Trinh B, Donath MY and Läubli H (2019) ‘Successful treatment of immune checkpoint inhibitor-induced diabetes with infliximab’, 42(9). Available at: https://doi.org/10.2337/dc19-0908.

Biver E, Calmy A and Meier C (2019) ‘Reply to “Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis. Comment on: Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis” by S. Noe, H. Jaeger, E. Wolf’, 30(8). Available at: https://doi.org/10.1007/s00198-019-05025-3.

Böni-Schnetzler M and Meier DT (2019) ‘Islet inflammation in type 2 diabetes’, Seminars in Immunopathology, 41(4), pp. 501–513. Available at: https://doi.org/10.1007/s00281-019-00745-4.

Donath MY (2019) ‘Inflammation and type 2 diabetes: from basic science to treatment’, 41(4). Available at: https://doi.org/10.1007/s00281-019-00749-0.

Urwyler SA et al. (2019) ‘Cytokines and Cortisol – predictors of treatment response to corticosteroids in community-acquired pneumonia?’, Journal of Internal Medicine, 286(1), pp. 75–87. Available at: https://doi.org/10.1111/joim.12891.

Donath MY, Meier DT and Böni-Schnetzler M (2019) ‘Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease’, Endocrine Reviews, 40(4), pp. 1080–1091. Available at: https://doi.org/10.1210/er.2019-00002.

Biver E et al. (2019) ‘Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis’, Osteoporosis International, 30(5), pp. 1125–1135. Available at: https://doi.org/10.1007/s00198-018-4794-0.

Struja T et al. (2019) ‘Comparison of Five TSH-receptor antibody assays in Graves” disease: Results from an observational pilot study’, BMC Endocrine Disorders, 19(1), p. 38. Available at: https://doi.org/10.1186/s12902-019-0363-6.

Hepprich, Matthias et al. (2019) ‘Novel insights into postprandial hypoglycemia after gastric bypass: Empagliflozin as well as Anakinra reduce symptomatic episodes by lowered insulin secretion’. SPRINGER HEIDELBERG, 60.

Kaiser N et al. (2019) ‘Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry.’, Molecular genetics and metabolism, 126(4), pp. 355–361. Available at: https://doi.org/10.1016/j.ymgme.2019.02.008.

Hatz K et al. (2019) ‘The prevalence of retinopathy in patients with type 1 diabetes treated with education-based intensified insulin therapy and its association with parameters of glucose control’, Diabetes Research and Clinical Practice, 148, pp. 234–239. Available at: https://doi.org/10.1016/j.diabres.2019.01.016.

Zulewski H et al. (2019) ‘Multidisciplinary approach for risk-oriented treatment of low-risk papillary thyroid cancer in Switzerland’, Swiss medical weekly, 149, p. w14700. Available at: https://doi.org/10.4414/smw.2019.14700.

Blum, Claudine A. et al. (2019) ‘Cosyntropin testing does not predict response to glucocorticoids in community-acquired pneumonia in a randomized controlled trial’, Clinical endocrinology, 91(3), pp. 374–382. Available at: https://doi.org/10.1111/cen.13907.

Hepprich, Matthias et al. (2019) ‘Hypothyroidism manifesting as multiple cranial neuropathies: a case report’, Journal of medical case reports, 13(1), p. 180. Available at: https://doi.org/10.1186/s13256-019-2124-6.